Search Browse Earnings

BIOMERICA INC

Nasdaq:BMRA

In Vitro & In Vivo Diagnostic Substances·IRVINE, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$5.4M

+1.4% YoY

FY 2025

Adj. EBITDA

-$6.0M

-111.3% margin

FY 2025

Net Income

-$6.0M

-110.4% margin

FY 2025

EPS (Diluted)

-$2.84

FY 2025

Stock Price

$2.23

+1.8%

2026-03-10

52W Range

$1.87 – $5.92

P/E Ratio

-0.8x

Market Cap

$6.7M

Cash

$4.2M

FY 2025

Total Debt

—

Net Cash

$4.2M

FY 2025

Enterprise Value

$2.6M

Debt / EBITDA

0.7x

FY 2025

EV / EBITDA

-0.4x

Employees

—

CEO

Irani Zackary S.

CFO

Lu Gary